Hydroxychloroquine and Its Effects on IgA Nephropathy
Author Information
Author(s): Yang Ting, Shi Yaotong, Wang Ye, Feng Yuan, Shao Qiuyuan, Jiang Chunming, Wang Lulu, Liu Jing
Primary Institution: Nanjing Drum Tower Hospital, Nanjing University, Nanjing, China
Hypothesis
What is the optimal range of hydroxychloroquine blood concentrations for treating IgA nephropathy in Chinese patients?
Conclusion
Hydroxychloroquine safely reduces proteinuria in Chinese patients with IgAN, and its efficacy is positively correlated with blood concentration.
Supporting Evidence
- The HCQ group had lower 24-h proteinuria than the RAASi group after six months.
- The percentage reduction in 24-h proteinuria was greater in the HCQ group at both three and six months.
- Hydroxychloroquine blood concentration and efficacy were positively correlated at three and six months.
Takeaway
This study found that a medicine called hydroxychloroquine can help kids with a kidney problem by making their pee less watery.
Methodology
This was a single-blind, randomized clinical trial involving 73 patients with biopsy-proven IgAN, comparing those treated with hydroxychloroquine plus RAASi to those receiving only RAASi.
Limitations
The study is limited by its single-center design, small sample size, and short follow-up period.
Participant Demographics
Patients were aged 18-75 years with biopsy-proven IgAN.
Statistical Information
P-Value
p<0.05
Confidence Interval
95% CI 0.81–1.00
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website